Varu DM, Rhee MK, Akpek EK, et al.; American Academy of Ophthalmology Preferred Practice Pattern Cornea and External Disease Panel. Conjunctivitis Preferred Practice Pattern®. Ophthalmology. 2019;126(1):P94-P169.
- Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment [published correction appears in JAMA. 2014;311(1):95]. JAMA. 2013;310(16):1721-1729.
Channa R, Zafar SN, Canner JK, et al. Epidemiology of eye-related emergency department visits. JAMA Opthalmol. 2016;134(3):312-319.
Pepose JS, Sarda SP, Cheng WY, et al. Direct and indirect costs of infectious conjunctivitis in a commercially insured population in the United States. Clin Ophthalmol. 2020;14:377-387.
Smith AF, Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC Ophthalmol. 2009;9:13.
Schneider JE, Scheibling CM, Segall D, et al. Epidemiology and economic burden of conjunctivitis: a managed care perspective. J Manag Care Med. 2014;17(1):78-83.
Mahoney MJ, Bekibele R, Notermann SL, et al. Pediatric conjunctivitis: a review of clinical manifestations, diagnosis, and management. Children (Basel). 2023;10(5):808.
Bielory L, Delgado L, Katelaris CH, et al. ICON: diagnosis and management of allergic conjunctivitis. Ann Allergy Asthma Immunol. 2020;124(2):118-134.
Patel DS, Arunakirinathan M, Stuart A, et al. Allergic eye disease. BMJ. 2017;359:j4706.
Dupuis P, Prokopich CL, Hynes A, et al. A contemporary look at allergic conjunctivitis. Allergy Asthma Clin Immunol. 2020;16:5.
Leonardi A, Silva D, Formigo DP, et al. Management of ocular allergy. Allergy. 2019;74(9):1611-1630.
Labib BA, Chigbu DI. Therapeutic targets in allergic conjunctivitis. Pharmaceuticals (Basel). 2022;15(5):547.
Bielory L, Wagle P. Ocular surface lubricants. Curr Opin Allergy Clin Immunol. 2017;17(5):382-389.
Drugs for allergic rhinitis and allergic conjunctivitis. Med Lett Drugs Ther. 2021;63(1622):57-64.
Pflipsen M, Massaquoi M, Wolf S. Evaluation of the painful eye. Am Fam Physician. 2016;93(12):991-998.
O’Brien TP, Jeng BH, McDonald M, et al. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin. 2009;25(8):1953-1961.
Johnson D, Liu D, Simel D. Does this patient with acute infectious conjunctivitis have a bacterial infection?: the rational clinical examination systematic review. JAMA. 2022;327(22):2231-2237.
Narayana S, McGee S. Bedside diagnosis of the ‘red eye’: a systematic review. Am J Med. 2015;128(11):1220-1224.e1.
Rietveld RP, ter Riet G, Bindels PJE, et al. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. BMJ. 2004;329(7459):206-210.
Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988–1994. J Allergy Clin Immunol. 2010;126(4):778-783.e6.
Patel S, Kaplan C, Galor A, et al. The role of temperature change, ambient temperature, and relative humidity in allergic conjunctivitis in a US veteran population. Am J Ophthalmol. 2021;230:243-255.
Verhelst D, Koppen C, Van Looveren J, et al.; Belgian Keratitis Study Group. Clinical, epidemiological and cost aspects of contact lens related infectious keratitis in Belgium: results of a seven-year retrospective study. Bull Soc Belge Ophtalmol. 2005(297):7-15.
Tsui E, Sella R, Tham V, et al.; SCORPIO Study Group. Pathogen surveillance for acute infectious conjunctivitis. JAMA Ophthalmol. 2023;141(12):1140-1144.
Patel PB, Diaz MCG, Bennett JE, et al. Clinical features of bacterial conjunctivitis in children. Acad Emerg Med. 2007;14(1):1-5.
Muto T, Imaizumi S, Kamoi K. Viral conjunctivitis. Viruses. 2023;15(3):676.
Marangon FB, Miller D, Alfonso E. Laboratory results in ocular viral diseases: implications in clinical-laboratory correlation. Arq Bras Oftalmol. 2007;70(2):189-194.
Aoki K, Tagawa Y. A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan. Int Ophthalmol Clin. 2002;42(1):49-54.
Zhang L, Zhao N, Sha J, et al. Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953–2013. Epidemiol Infect. 2016;144(8):1661-1672.
Gordon YJ, Gordon RY, Romanowski E, et al. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology. 1993;100(12):1835-1839.
Domínguez-Berjón MF, Hernando-Briongos P, Miguel-Arroyo PJ, et al. Adenovirus transmission in a nursing home: analysis of an epidemic outbreak of keratoconjunctivitis. Gerontology. 2007;53(5):250-254.
Johnson SD, Harthan JS, Than T, et al. Predictive accuracy and densitometric analysis of point-of-care immunoassay for adenoviral conjunctivitis. Transl Vis Sci Technol. 2021;10(9):30.
Kam KY, Ong HS, Bunce C, et al. Sensitivity and specificity of the AdenoPlus point-of-care system in detecting adenovirus in conjunctivitis patients at an ophthalmic emergency department: a diagnostic accuracy study. Br J Ophthalmol. 2015;99(9):1186-1189.
Choosing Wisely: five things ophthalmologists and patients should question. American Academy of Ophthalmology. Accessed October 13, 2023. https://www.aao.org/education/choosing-wisely
Holland EJ, Fingeret M, Mah FS. Use of topical steroids in conjunctivitis: a review of the evidence. Cornea. 2019;38(8):1062-1067.
Roba LA, Kowalski RP, Gordon AT, et al. Adenoviral ocular isolates demonstrate serotype-dependent differences in in vitro infectivity titers and clinical course. Cornea. 1995;14(4):388-393.
Lee T, Kuo IC. Survey of state conjunctivitis policies for school-age students. J AAPOS. 2022;26(3):115.e1-115.e5.
Centers for Disease Control and Prevention. Clinical overview of pink eye (conjunctivitis). April 15, 2024. Accessed June 1, 2024. https://www.cdc.gov/conjunctivitis/hcp/clinical-overview/index.html
Leonardi A, Modugno RL, Salami E. Allergy and dry eye disease. Ocul Immunol Inflamm. 2021;29(6):1168-1176.
- Liu X, Wang G, He J, et al. Novel application of immunochromatographic assay for measurement of total tear immunoglobulin E. Cornea. 2024;43(1):13-17.
Bao J, Tian L, Meng Y, et al. Total IgE in tears accurately reflects the severity and predicts the prognosis of seasonal allergic conjunctivitis. Clin Transl Allergy. 2022;12(3):e12139.
Goldstein MH, Silva FQ, Blender N, et al. Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond). 2022;36(2):361-368.
Yáñez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002;89(5):479-484.
Ilyas H, Slonim CB, Braswell GR, et al. Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis. Eye Contact Lens. 2004;30(1):10-13.
Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005;24(9):823-828.
Jefferis J, Perera R, Everitt H, et al. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. Br J Gen Pract. 2011;61(590):e542-e548.
Rose P. Management strategies for acute infective conjunctivitis in primary care. Expert Opin Pharmacother. 2007;8(12):1903-1921.
Chen YY, Liu SH, Nurmatov U, et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2023(3):CD001211.
Sonoda K, Takeuchi Y. Antibiotics for acute bacterial conjunctivitis. Am Fam Physician. 2023;107(6) ): Online. Accessed May 27, 2024. https://www.aafp.org/pubs/afp/issues/2023/0600/mbtn-acute-bacterial-conjunctivitis.html
Everitt HA, Little PS, Smith PWF. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice [published correction appears in BMJ. 2006; 333(7566): 468]. BMJ. 2006;333(7563):321.
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
Morrow GL, Abbott RL. Conjunctivitis. Am Fam Physician. 1998;57(4):735-746.